Physician profile
Caroline Hendricks
NPI 1306334560
$1,106.06
in general payments reported to CMS, 2019-2025
18 companies · $453 in 2025
The $453 reported for 2025 was more than what 92% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16.67 · 2021: $19.26 · 2022: $49.10 · 2023: $293 · 2024: $275 · 2025: $453.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,021.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,021.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanofi-Aventis U.S. LLC | $203.27 | 2024-2025 | |
| Collegium Pharmaceutical, INC. | $175.72 | 2025 | Jornay Pm |
| Corium, LLC | $156.60 | 2023-2024 | Azstarys |
| Pfizer INC. | $94.14 | 2023-2025 | |
| Glaxosmithkline, LLC. | $76.77 | 2025 | Bexsero, Penmenvy, Rotarix |
| Tris Pharma INC | $73.62 | 2021-2023 | Dyanavel Xr |
| Cranial Technologies, INC | $64.47 | 2022-2024 | Doc Band |
| Neuraxis, INC. | $59.56 | 2024 | |
| Lnhc, INC | $34.18 | 2025 | Zelsuvmi |
| Ironshore Pharmaceuticals INC. | $32.69 | 2023 | Jornay Pm |
| Seqirus USA INC | $18.64 | 2023 | Flucelvax Quadrivalent |
| Biomerieux INC | $18.36 | 2025 | |
| Verrica Pharmaceuticals INC. | $18.01 | 2025 | Ycanth |
| Alexion Pharmaceuticals, INC. | $17.05 | 2023 | Koselugo |
| Csl Behring | $16.67 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $15.63 | 2025 | Qelbree |
| Hologic Sales and Service, LLC | $15.53 | 2023 | Aptima |
| Neos Therapeutics, LP | $15.15 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Caroline Hendricks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.